(Invited) Brief Review: Nanoparticle-based Drug Delivery — A Historical Overview

This brief historical review depicts recent advancements in nanoparticle-based drug delivery systems, as they have been reported in the journal Nano LIFE for the past 15 years. We begin by summarizing the types of materials used to create nanoparticles, including liposomes, polymers, metals, and carbon-based structures. We then describe their passive targeting properties and various functionalization strategies used to provide active targeting, thus improving their selectivity in vivo. We also explain the emerging use of nanoparticle drug delivery systems for applications beyond cancer therapy, such as in immune modulation and orthopedic areas. Some of the future challenges highlighted include large-scale production and regulatory hurdles, and future areas of growth include artificial intelligence-driven optimization and biogenic manufacturing.

Authors

Institutions

Publication Details

Journal
Nano LIFE
Published
2025-04-22
DOI
https://doi.org/10.1142/s1793984425410028
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

(Invited) Brief Review: Nanoparticle-based Drug Delivery — A Historical Overview

François Berthiaume
Nano LIFE
Nanoparticle-Based Drug Delivery
article

(Invited) Brief Review: Nanoparticle-based Drug Delivery — A Historical Overview

François Berthiaume
article en

Abstract

This brief historical review depicts recent advancements in nanoparticle-based drug delivery systems, as they have been reported in the journal Nano LIFE for the past 15 years. We begin by summarizing the types of materials used to create nanoparticles, including liposomes, polymers, metals, and carbon-based structures. We then describe their passive targeting properties and various functionalization strategies used to provide active targeting, thus improving their selectivity in vivo. We also explain the emerging use of nanoparticle drug delivery systems for applications beyond cancer therapy, such as in immune modulation and orthopedic areas. Some of the future challenges highlighted include large-scale production and regulatory hurdles, and future areas of growth include artificial intelligence-driven optimization and biogenic manufacturing.

Nano LIFEVol. 15(06)
Rutgers, The State University of New Jersey (US)
Openalex Percentile: Top 95%
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

(Invited) Brief Review: Nanoparticle-based Drug Delivery — A Historical Overview — François Berthiaume · Nano LIFE (2025) | TGRS Research Map | TGRS